Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani helicobacter pylori

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 4, 2009, Pages 631-636

  Zaidi, Syed Faisal Haider ^a   Yoshida, Ikuko ^b   Butt, Farhana ^c   Yusuf, Muhammed Aasim ^c   Usmanghani, Khan ^d   Kadowaki, Makoto ^a   Sugiyama, Toshiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOYAMA UNIVERSITY HOSPITAL   (Japan)

^c SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

^d HAMDARD UNIVERSITY   (Pakistan)

Author keywords

Anti helicobacter pylori activity; Clarithromycin resistant; Mallotus philippinensis; Metronidazole resistant; Rottlerin

Indexed keywords

3' PRENYLRUBRANINE; 5,7 DIHYDRO 8 METHYL 6 PRENYLFLAVANONE; AMOXICILLIN; BACTERICIDE; CLARITHROMYCIN; ISOROTTLERIN; KAMALA EXTRACT; METRONIDAZOLE; RED COMPOUND; RIBOSOME RNA; ROTTLERIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SYNTHESIS; GENE DELETION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IN VITRO STUDY; JAPANESE; MALLOTUS PHILIPPINENSIS; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAKISTAN; POINT MUTATION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FRUIT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MAGNETIC RESONANCE SPECTROSCOPY; MALLOTUS PLANT; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PAKISTAN; POINT MUTATION;

EID: 65249165416     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.631     Document Type: Article

References (32)

1. Suerbaum S., Michetti P., N. Engl. J. Med., 347, 1175-1186(2002).
2. Goodwin C. S., Armstrong J. A., Eur. J. Clin. Microbiol. Infect. Dis., 9, 1-13(1990).
3. Covacci A., Telford J. L., Giudice G. D., Parsonnet J., Rappuoli R., Science, 284, 1328-1333(1999).
4. Sepulveda A. R., Coelho L. G. V., Helicobacter, 7, 37-12(2002).
5. Hentschel E., Brandstatter G., Dragsics B., Hirschil A. M., Nemec H., Schutze K., Taufer M., Wurzer H., N. Engl. J. Med., 328, 308-312(1993).
6. Megraud F., Aliment. Pharmacol. Ther., 11, 43-53(1997).
7. Mendonca S., Ecclissato C., Sartori M. S., Godoy A. P., Guerzoni R. A., Degger M., Pedrazzoli J. Jr., Helicobacter, 5, 79-83(2000).
8. O'Gara E. A., Hill D. J., Maslin D. J., Appl. Environ. Microbiol., 66, 2269-2273(2000).
9. Thompson C. J., Ernst E., Aliment. Pharmacol. Ther., 16, 1689-1699(2002).
10. Zaidi S. F. H., Yamada K., Kadowaki M., Usmanghani K., Sugiyama T., J. Ethnopharm., 121, 286-291(2009).
11. Furusawa M., Ido Y., Tanaka T., Ito T., Nakaya K., Ibrahim I., Ohyama M., Iinuma M., Shirataka Y., Takahashi Y., Helv. Chim. Acta, 88, 1048-1058(2005).
12. Ahluwalia V K., Sharma N. D., Mittal B., Gupta S. R., Indian J. Chem., 27, 238-241(1988).
13. Lounasmaa M., Widen C.-J., Tiff C.-M., Huhtikangas A., Planta Med., 28, 16-31(1975).
14. Nagasako T., Sugiyama T., Mizushima T., Miura Y., Kato M., Asaka M., J. Biol. Chem., 278, 4821-1825(2003).
15. Meyer F., Wilson K. T., James S. P., Infect. Immun., 68, 6265-6272(2000).
16. Kneller R. W., Wan-De G., Hsing A. W., Chen J. S., Blot W. J., Li J. Y., Forman D., Fraumeni J. F., Cancer Epidemol. Biomarkers Prevent., 113, 113-118(1992).
17. Jemal A., Thomas A., Murray T., Thun M., CA Cancer J. Clin., 52, 23-47(2002).
18. Sugiyama T., Asaka M., Med. Electron Microsc., 37, 149-157(2004)
19. IARC Working Group on the evaluation of carcinogenic risks to humans, "Schistosomes, Liver flukes and Helicobater pylori. Infections with Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans," Vol. 61, International Agency for Research on Cancer, Lyon, 1994, pp. 177-201.
20. Usmanghani K., Saeed A., Alam M. T., "Indusynic Medicine, Research Institute of Indusyunic Medicine," A-952, Block H., North Nazimabad, Karachi, 1997, pp. 285-287.
21. Jabbar A., Raza M. A., Iqbal Z., Khan M. N., J. Ethnopharm., 108, 152-154(2006).
22. Kumar V. P., Chauhan N. S., Padh H., Rajani M., J. Ethnopharm., 107, 182-188(2006).
23. Daikonya A., Katsuki S., Wu J.-B., Kitanaka S., Chem. Pharm. Bull., 50, 1566-1659(2002).
24. Soltoff S. P., Trends Pharmacol. Sci., 28, 453-458(2007).
25. Asaka M., Sugiyama T., Kato M., Satoh K., Kuwayama H., Fukuda Y., Fujioka T., Takemoto T., Kimura K., Shimoyama T., Shimizu K., Kobayashi S., Helicobacter, 6, 254-261(2001).
26. Adamek R. J., Suerbaum S., Pfaffenbach B., Opferkuch W., Am. J. Gastroenterol., 93, 386-389(1998).
27. Miyaji H., Azuma T., Ito S., Suto H., ItoY., Yamazaki Y., Sato F., Hirai M., Kuriyama M., Kato T., Kohli Y., Aliment. Pharmacol. Ther., 11, 1131-1136(1997).
28. Malfertheiner P., MMWFortschr. Med., 145, 42-45(2003).
29. Dunn B. E., Cohen H., Blaser M. J., Clin. Microbiol. Rev., 10, 720-741(1997).
30. Versalovic J., Osato M. S., Spakovsky K., Dore M. P., Reddy R., Stone G. G., Shortridge D., Flamm R. K., Tanaka S. K., Graham D. Y., J. An- timicrob. Chemother., 40, 283-286(1997).
31. Umegaki N., Shimoyama T., Nishiya D., Suto T., Fukuda S., Munakata A., J. Gastroenterol. Hepatol., 15, 906-909(2000).
32. Rimbara E., Noguchi N., Kijima H., Yamaguchi T., Kawai T., Sasatsu M., Int. J. Antimicrob. Agents, 30, 250-254(2007).